Business Context and Reporting Period
Company: Yatsen Holding Ltd (Yatsen)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Yatsen is a leading China-based beauty group operating a digitally native direct-to-consumer (DTC) model. The company manages a portfolio of color cosmetics brands (e.g., Perfect Diary, Little Ondine, Pink Bear) and skincare brands (e.g., Galénic, DR.WU, Eve Lom). Operations are conducted primarily through PRC subsidiaries and a Variable Interest Entity (VIE) structure due to foreign ownership restrictions in China.
Key Financial Metrics (2024)
| Metric | 2024 (RMB '000) | 2024 (US$ '000) | 2023 (RMB '000) | 2022 (RMB '000) |
|---|---|---|---|---|
| Total Net Revenues | 3,393,414 | 464,896 | 3,414,774 | 3,706,122 |
| Gross Profit | 2,617,178 | 358,552 | 2,513,319 | 2,518,752 |
| Gross Margin | 77.1% | 77.1% | 73.6% | 68.0% |
| Net Loss | (710,221) | (97,299) | (750,227) | (821,333) |
| Net Loss Margin | 20.9% | 20.9% | 22.0% | 22.2% |
| Operating Cash Flow | (243,666) | (33,382) | (107,442) | 136,208 |
| Cash & Equivalents (Year End) | 817,395 | 111,983 | 858,136 | 1,554,328 |
| Short-term Investments | 539,130 | 73,861 | 1,218,481 | 1,218,481 |
Material Changes vs. Prior Period
- Revenue Decline: Total net revenues decreased by 0.6% to RMB 3.39 billion in 2024 compared to 2023. This was driven by a decline in Color Cosmetics Brands revenue (down 0.3%), partially offset by growth in Skincare Brands revenue (up 0.7%).
- Margin Expansion: Gross margin improved significantly to 77.1% from 73.6% in 2023, attributed to a higher mix of high-margin skincare products and disciplined pricing strategies.
- Goodwill Impairment: The company recorded a goodwill impairment charge of RMB 403.1 million (US$ 55.2 million) in 2024, primarily related to the Eve Lom reporting unit due to weaker operating results than expected. This compares to RMB 354.0 million in 2023.
- Operating Expenses: Selling and marketing expenses increased slightly to RMB 2.27 billion (66.9% of revenue) due to higher channel traffic costs on the Douyin platform. General and administrative expenses decreased to RMB 444.4 million due to headcount reductions.
- Cash Flow: Operating cash flow turned negative at RMB (243.7) million, compared to RMB (107.4) million in 2023, largely due to changes in working capital and increased prepayments.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Yatsen continues to execute a strategic transformation plan focusing on building a sustainable brand portfolio. The company is prioritizing higher-margin products, expanding its skincare portfolio (Galénic, DR.WU, Eve Lom), and optimizing its color cosmetics lineup. Management expects to continue investing in R&D and brand equity while optimizing channel mix and marketing efficiency. No specific numerical guidance for 2025 was provided in the text.
Key Risks & Contingencies:
- VIE Structure Risks: The company operates through a VIE structure in China. Uncertainties regarding PRC laws and the enforceability of contractual arrangements could materially adversely affect operations and financial performance.
- Regulatory Environment: Significant risks exist regarding PRC regulations on data security, cybersecurity, and overseas listings (CSRC filing requirements). New regulations effective January 1, 2025, impose stricter data security obligations.
- Market Competition: The beauty industry is highly competitive. Failure to anticipate consumer trends or launch successful new products could lead to market share loss.
- Goodwill Impairment: Continued underperformance of acquired brands (specifically Eve Lom) may lead to further impairment charges.
- Share Repurchase Program: As of February 28, 2025, the company had repurchased approximately US$ 199.9 million of ADSs under its program, which is authorized up to US$ 200.0 million through November 2025.
Investor Verification Checklist
- Goodwill Valuation: Verify the assumptions used in the discounted cash flow model for the Eve Lom reporting unit, specifically revenue growth rates and discount rates, given the recurring impairment charges.
- Skincare Brand Performance: Confirm the sustainability of revenue growth in the Skincare segment (Galénic, DR.WU, Eve Lom) as the primary offset to declining color cosmetics sales.
- Marketing Efficiency: Analyze the return on investment (ROI) for marketing spend, particularly the increasing costs associated with the Douyin platform, to ensure margin expansion is not eroded by rising customer acquisition costs.
- Regulatory Compliance: Review the company's compliance status with the new PRC "Regulation on Network Data Security Management" effective January 1, 2025, and any potential impact on cross-border data transfer or operations.
- Liquidity Position: Assess the sufficiency of cash and short-term investments (approx. US$ 186 million combined) to fund operations given the negative operating cash flow and ongoing share repurchase activities.